COSYNTROPIN (koe-sin-troe'pin) Cortrosyn Classifications: diagnostic agent Prototype: Prednisone Pregnancy Category: C |
0.25 mg injection
Synthetic polypeptide resembling corticotropin (ACTH) in relation to the first 24 of the 39 amino acids in naturally occurring ACTH. Has less immunologic activity and is associated with less risk of sensitivity than corticotropin.
In patient with normal adrenocortical function, stimulates adrenal cortex to secrete corticosterone, cortisol (hydrocortisone), several weak androgenic substances, and limited amounts of aldosterone.
Diagnostic tool to differentiate primary adrenal from secondary (pituitary) adrenocortical insufficiency.
In patients with normal adrenocortical function for the long-term treatment of chronic inflammatory or degenerative disorders responsive to glucocorticoids.
History of allergic disorders; scleroderma, osteoporosis; systemic fungal infections, ocular herpes simplex; recent surgery; history of or presence of peptic ulcer; CHF; hypertension; adrenocortical insufficiency and adrenocortical hyperfunction; pregnancy (category C), lactation; immunizations, tuberculosis, infections.
Multiple sclerosis, acute gouty arthritis, mental disturbances, diabetes, abscess, pyrogenic infections, diverticulitis, renal insufficiency, myasthenia gravis, children.
Rapid Screening Test Adult/Child: >2 y: IM/IV 0.25 mg injected over 2 min Child: <2 y: IM 0.125 mg injected over 2 min; IV 0.125 mg at 0.04 mg/h over 6 h Neonate: IM/IV 0.015 mg/kg |
Intravenous
PREPARE: Direct: Reconstitute as for IM. IV Infusion: Further dilute in 250500 mL of D5W or NS. ADMINISTER: Direct: Give over 2 min. IV Infusion: Give at an approximate rate of 40 mcg/h over 46 h. |
Cortisone, hydrocortisone, estrogen, spironolactone elevated bilirubin, and presence of free Hgb in plasma may interfere with plasma cortisol determinations.
Assessment & Drug Effects